BANK OF AMERICA CORP /DE/

Bank

Position in DNLI — Denali Therapeutics Inc.

CIK 70858 CHARLOTTE, NC

Back to DNLI Full portfolio

Position in DNLI

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$21,776,313

+$6,386,619 QoQ

Shares Held

1,134,183

+21.7% QoQ

Ownership

0.715%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 89.25164633925918.ToString("F0")% Shared 0.ToString("F0")% None 10.748353660740815.ToString("F0")%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. DNLI ranks #76 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,878,183	$1,285,223,834
2	REGN	Regeneron Pharmaceuticals, Inc.	1,189,584	$919,120,177
3	ALNY	Alnylam Pharmaceuticals, Inc.	966,912	$319,922,169
4	ARGX	Argenx SE	400,117	$292,185,437
5	INSM	INSMED Inc	1,502,281	$245,652,986
6	CYTK	Cytokinetics Inc	3,125,436	$205,997,485
7	JAZZ	Jazz Pharmaceuticals plc	1,014,800	$191,847,936
8	HALO	Halozyme Therapeutics, Inc.	2,913,109	$188,274,232

All Filings in DNLI

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,776,313	1,134,183	+21.7%	Shares	Defined	2026-05-18
2025-12-31	$15,389,694	932,144	-3.0%	Shares	Defined	2026-02-17
2025-09-30	$13,955,721	961,138	+47.8%	Shares	Defined	2026-02-03
2025-06-30	$9,096,603	650,222	+45.2%	Shares	Defined	2025-08-14
2025-03-31	$6,087,254	447,757	+65.6%	Shares	Defined	2025-05-15
2024-12-31	$5,509,384	270,333	-22.4%	Shares	Defined	2025-02-14
2024-09-30	$10,142,014	348,164	-53.1%	Shares	Defined	2024-11-14
2024-06-30	$17,230,352	742,048	-12.9%	Shares	Defined	2024-08-14
2024-03-31	$17,482,546	851,976	+85.8%	Shares	Defined	2024-05-15
2023-12-31	$9,842,370	458,638	+55.1%	Shares	Defined	2024-02-14
2023-09-30	$6,102,228	295,794	+9.5%	Shares	Defined	2023-11-14
2023-06-30	$7,974,927	270,245	-35.6%	Shares	Defined	2023-08-14
2023-03-31	$9,673,019	419,836	+25.4%	Shares	Defined	2023-05-12
2022-12-31	$9,310,006	334,772	+52.0%	Shares	Defined	2023-02-10
2022-09-30	$6,758,456	220,217	+85.0%	Shares	Defined	2022-11-14
2022-06-30	$3,504,139	119,067	-50.6%	Shares	Defined	2022-08-12
2022-03-31	$7,760,526	241,235	+87.1%	Shares	Defined	2022-05-16
2021-12-31	$5,751,080	128,948	+65.6%	Shares	Defined	2022-02-08
2021-09-30	$3,927,329	77,846	+22.1%	Shares	Defined	2021-11-15
2021-06-30	$5,000,703	63,752	+23.1%	Shares	Defined	2021-09-13
2021-03-31	$2,956,122	51,771	+9.5%	Shares	Defined	2021-05-14
2020-12-31	$3,961,343	47,294	+62.5%	Shares	Defined	2021-02-10
2020-09-30	$1,042,759	29,103	-12.9%	Shares	Defined	2020-11-13
2020-06-30	$807,852	33,410	+21.0%	Shares	Defined	2020-08-14
2020-03-31	$483,433	27,609	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.